Toll Free: 1-888-928-9744

Asklepios BioPharmaceutical, Inc. - Product Pipeline Review - 2015

Published: May, 2015 | Pages: 23 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Asklepios BioPharmaceutical, Inc. - Product Pipeline Review - 2015

Summary

Global Markets Direct's, 'Asklepios BioPharmaceutical, Inc. - Product Pipeline Review - 2015', provides an overview of the Asklepios BioPharmaceutical, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Asklepios BioPharmaceutical, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Asklepios BioPharmaceutical, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Asklepios BioPharmaceutical, Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Asklepios BioPharmaceutical, Inc.'s pipeline products

Reason to Buy

- Evaluate Asklepios BioPharmaceutical, Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Asklepios BioPharmaceutical, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Asklepios BioPharmaceutical, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Asklepios BioPharmaceutical, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Asklepios BioPharmaceutical, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
- Explore the dormant and discontinued projects of Asklepios BioPharmaceutical, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 3 Asklepios BioPharmaceutical, Inc. Snapshot 4 Asklepios BioPharmaceutical, Inc. Overview 4 Key Information 4 Key Facts 4 Asklepios BioPharmaceutical, Inc. - Research and Development Overview 5 Key Therapeutic Areas 5 Asklepios BioPharmaceutical, Inc. - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Asklepios BioPharmaceutical, Inc. - Pipeline Products Glance 9 Asklepios BioPharmaceutical, Inc. - Clinical Stage Pipeline Products 9 Phase I Products/Combination Treatment Modalities 9 Asklepios BioPharmaceutical, Inc. - Early Stage Pipeline Products 10 Preclinical Products/Combination Treatment Modalities 10 Discovery Products/Combination Treatment Modalities 11 Asklepios BioPharmaceutical, Inc. - Drug Profiles 12 Biostrophin 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 BNP-CHF 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 BNP-TLE 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 BNP-OA 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 BNP-RP 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 Asklepios BioPharmaceutical, Inc. - Pipeline Analysis 17 Asklepios BioPharmaceutical, Inc. - Pipeline Products by Target 17 Asklepios BioPharmaceutical, Inc. - Pipeline Products by Route of Administration 18 Asklepios BioPharmaceutical, Inc. - Pipeline Products by Molecule Type 19 Asklepios BioPharmaceutical, Inc. - Pipeline Products by Mechanism of Action 20 Asklepios BioPharmaceutical, Inc. - Locations And Subsidiaries 21 Head Office 21 Appendix 22 Methodology 22 Coverage 22 Secondary Research 22 Primary Research 22 Expert Panel Validation 22 Contact Us 22 Disclaimer 23
List of Tables
Asklepios BioPharmaceutical, Inc., Key Information 4 Asklepios BioPharmaceutical, Inc., Key Facts 4 Asklepios BioPharmaceutical, Inc. - Pipeline by Indication, 2015 6 Asklepios BioPharmaceutical, Inc. - Pipeline by Stage of Development, 2015 7 Asklepios BioPharmaceutical, Inc. - Monotherapy Products in Pipeline, 2015 8 Asklepios BioPharmaceutical, Inc. - Phase I, 2015 9 Asklepios BioPharmaceutical, Inc. - Preclinical, 2015 10 Asklepios BioPharmaceutical, Inc. - Discovery, 2015 11 Asklepios BioPharmaceutical, Inc. - Pipeline by Target, 2015 17 Asklepios BioPharmaceutical, Inc. - Pipeline by Route of Administration, 2015 18 Asklepios BioPharmaceutical, Inc. - Pipeline by Molecule Type, 2015 19 Asklepios BioPharmaceutical, Inc. - Pipeline Products by Mechanism of Action, 2015 20



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify